Assignee
HYLORIS DEV SA
BE·6 granted patents·8 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
14 records- 0176US11413241B2Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereofHYLORIS DEV SA·Filed 2018·Granted Aug 16, 2022·1 cites·18 claims
- 0273US12508315B2Use of vitamin E TPGS as a taste masking agent for bitter drugsHYLORIS DEV SA·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 0363US2025345436A1Use of vitamin e tpgs as a taste masking agent for bitter drugsHYLORIS DEV SA·Filed 2025·Application pending·0 cites
- 0462US2024024235A1Tranexamic acid oral solutionHYLORIS DEV SA·Filed 2023·Application pending·0 cites
- 0561US2025350689A1Intravenous dofetilide and uses thereofHYLORIS DEV SA·Filed 2025·Application pending·0 cites
- 0660US12343320B2Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgeryHYLORIS DEV SA·Filed 2023·Granted Jul 1, 2025·0 cites·23 claims
- 0760US2024285558A1Intraveneous dofetilide to terminate arrhythmic storm following implantation of a cardiac defibrilatorHYLORIS DEV SA·Filed 2023·Application pending·0 cites
- 0859US2025032417A1Lyophilized metolazone formulation for parenteral administrationHYLORIS DEV SA·Filed 2024·Application pending·0 cites
- 0956US12521357B2Intravenous dofetilide to convert atrial fibrillation/flutterHYLORIS DEV SA·Filed 2023·Granted Jan 13, 2026·0 cites·20 claims
- 1056US12357644B2Acetyl salicylic acid composition for intravenous administration, its storage, production and useHYLORIS DEV SA·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 1155US2025235455A1Aqueous ticagrelor solutions, method of manufacturing and usesHYLORIS DEV SA·Filed 2023·Application pending·0 cites
- 1247US11666532B2Tranexamic acid oral solutionHYLORIS DEV SA·Filed 2019·Granted Jun 6, 2023·0 cites·12 claims
- 1345US2019216823A1Methylprednisolone pharmaceutical suspensionHYLORIS DEV SA·Filed 2019·Application pending·0 cites
- 1440US2026007599A1Ticagrelor iv formulations for use in the treatment of gram-positive bacteremiaHYLORIS DEV SA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HYLORIS DEV SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →